Research Article
Applying NGS Data to Find Evolutionary Network Biomarkers from the Early and Late Stages of Hepatocellular Carcinoma
Table 5
The intersection of the total-stage liver cancer with our previous result.
| | Protein | CRV
(in this study) | value
(in this study) | CRV
(previous) | value
(previous) |
| | BUB1B | 7.58 | 0.005833 | 5.5696 | 0.00064 | | CDC20 | 11.28 | 0.002011 | 5.1507 | 0.00109 | | CDK2 | 6.9 | 0.007708 | 14.069 |
< | | CUL3 | 8.16 | 0.004478 | 12.9519 | < | | E2F1 | 10.19 | 0.002497 | 3.9947 | 0.00862 | | ESR1 | 23.79 | 0.000652 | 10.3758 | < | | HDAC4 | 10.11 | 0.002531 | 5.8397 | 0.00048 | | HGS | 15.2 | 0.001329 | 4.6929 | 0.00232 | | MYC | 7.55 | 0.005884 | 10.7821 | < | | PCNA | 13.58 | 0.001572 | 15.1438 | < | | PRKDC | 8.19 | 0.004418 | 5.9369 | 0.00041 | | SMARCA4 | 13.21 | 0.001611 | 7.7449 | 0.0001 | | SUMO1 | 10.36 | 0.002373 | 15.8533 | < | | TRAF2 | 14.28 | 0.001461 | 4.7703 | 0.00207 | | UBC | 25.19 | 0.000588 | 137.284 | < |
|
|
